XML 40 R22.htm IDEA: XBRL DOCUMENT v3.3.1.900
Segment Information
12 Months Ended
Dec. 31, 2015
Segment Reporting [Abstract]  
Segment Information
Segment Information

The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of the operating segment performance because it excludes the impact of corporate-driven decisions related to interest expense and income taxes.

The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock unit awards, research and development costs, Corporate overhead costs, restructuring and related implementation costs, and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments. 

Approximately 75% of the Company’s Net sales are generated from markets outside the U.S., with over 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). Oral, Personal and Home Care sales to Wal-Mart Stores, Inc. and its affiliates represent approximately 11% of the Company's Net sales in 2015. No other customer represents more than 10% of Net sales.

In 2015, Corporate Operating profit (loss) includes charges of $1,084 related to the change in accounting for the Company’s Venezuelan operations, $254 related to the 2012 Restructuring Program, $34 related to the remeasurement of CP Venezuela’s local currency-denominated net monetary assets as a result of effective devaluations and $14 for a foreign competition law matter and included a gain of $187 on the sale of the Company’s laundry detergent business in the South Pacific. In 2014, Corporate Operating profit (loss) includes charges of $286 related to the 2012 Restructuring Program, $327 related to the remeasurement of CP Venezuela’s local currency-denominated net monetary assets as a result of effective devaluations and $41 for foreign competition law matters and costs of $4 related to the sale of land in Mexico. In 2013, Corporate Operating profit (loss) included charges of $371 related to the 2012 Restructuring Program, $172 related to the remeasurement of CP Venezuela’s local currency-denominated net monetary assets as a result of a devaluation and $23 for a foreign competition law matter and costs of $18 related to the sale of land in Mexico. For further information regarding the 2012 Restructuring Program, refer to Note 4, Restructuring and Related Implementation Charges. For further information regarding Venezuela, refer to Note 14, Venezuela. For further information regarding the foreign competition law matters, refer to Note 13, Commitments and Contingencies. For further information regarding the sale of land in Mexico and the sale of the Company’s laundry detergent business in the South Pacific, refer to Note 3, Acquisitions and Divestitures.

 
 
2015
 
2014
 
2013
Net sales
 
 
 
 
 
 
Oral, Personal and Home Care
 
 
 
 
 
 
North America(1)
 
$
3,149

 
$
3,124

 
$
3,072

Latin America
 
4,327

 
4,769

 
5,012

Europe/South Pacific
 
2,870

 
3,406

 
3,396

Asia
 
2,478

 
2,515

 
2,472

Africa/Eurasia
 
998

 
1,208

 
1,257

Total Oral, Personal and Home Care
 
13,822

 
15,022

 
15,209

Pet Nutrition(2)
 
2,212

 
2,255

 
2,211

Total Net sales
 
$
16,034

 
$
17,277

 
$
17,420

_________
(1) 
Net sales in the U.S. for Oral, Personal and Home Care were $2,896, $2,835 and $2,771 in 2015, 2014 and 2013, respectively.
(2) 
Net sales in the U.S. for Pet Nutrition were $1,223, $1,149 and $1,116 in 2015, 2014 and 2013, respectively.

 
 
2015
 
2014
 
2013
Operating profit
 
 
 
 
 
 
Oral, Personal and Home Care
 
 

 
 

 
 
North America
 
$
974

 
$
926

 
$
927

Latin America
 
1,209

 
1,279

 
1,385

Europe/South Pacific
 
750

 
877

 
805

Asia
 
753

 
736

 
698

Africa/Eurasia
 
178

 
235

 
268

Total Oral, Personal and Home Care
 
3,864

 
4,053

 
4,083

Pet Nutrition
 
612

 
592

 
563

Corporate
 
(1,687
)
 
(1,088
)
 
(1,090
)
Total Operating profit
 
$
2,789

 
$
3,557

 
$
3,556


 
 
2015
 
2014
 
2013
Capital expenditures
 
 
 
 
 
 
Oral, Personal and Home Care
 
 

 
 

 
 
North America
 
$
207

 
$
136

 
$
54

Latin America
 
110

 
205

 
235

Europe/South Pacific
 
42

 
78

 
74

Asia
 
119

 
147

 
123

Africa/Eurasia
 
12

 
14

 
11

Total Oral, Personal and Home Care
 
490

 
580

 
497

Pet Nutrition
 
34

 
40

 
45

Corporate
 
167

 
137

 
128

Total Capital expenditures
 
$
691

 
$
757

 
$
670


 
 
2015
 
2014
 
2013
Depreciation and amortization
 
 
 
 
 
 
Oral, Personal and Home Care
 
 

 
 

 
 
North America
 
$
47

 
$
43

 
$
51

Latin America
 
88

 
93

 
93

Europe/South Pacific
 
72

 
84

 
85

Asia
 
94

 
78

 
72

Africa/Eurasia
 
8

 
10

 
11

Total Oral, Personal and Home Care
 
309

 
308

 
312

Pet Nutrition
 
52

 
52

 
51

Corporate
 
88

 
82

 
76

Total Depreciation and amortization
 
$
449

 
$
442

 
$
439


 
 
2015
 
2014
 
2013
Identifiable assets
 
 
 
 
 
 
Oral, Personal and Home Care
 
 
 
 
 
 
North America
 
$
2,622

 
$
2,326

 
$
2,301

Latin America
 
2,314

 
3,693

 
4,202

Europe/South Pacific
 
3,457

 
3,836

 
3,978

Asia
 
1,882

 
1,903

 
1,794

Africa/Eurasia
 
476

 
510

 
557

Total Oral, Personal and Home Care
 
10,751

 
12,268

 
12,832

Pet Nutrition
 
1,006

 
1,051

 
1,087

Corporate(1)
 
201

 
140

 
66

Total Identifiable assets(2)
 
$
11,958

 
$
13,459

 
$
13,985

____________
(1) 
In 2015, Corporate identifiable assets primarily consist of derivative instruments (67%) and investments in equity securities (20%). In 2014, Corporate identifiable assets primarily consist of derivative instruments (62%) and investments in equity securities (22%). In 2013, Corporate identifiable assets primarily consist of derivative instruments (32%) and investments in equity securities (41%). 
(2) 
Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-third of total long-lived assets of $7,420, $8,086 and $8,248 in 2015, 2014 and 2013, respectively.